Selected research
Industry Research
Glucosamine Hydrochloride API Industry Research Report 2026
Market perspective
The global Glucosamine Hydrochloride API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glucosamine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glucosamine Hydrochloride API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glucosamine Hydrochloride API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glucosamine Hydrochloride API include Andhra Medi Pharma, Bioiberica, KOYO Chemical, Panvo Organics, TSI, Wanbury Limited, Fujian huakang pharmaceutical, Shandong Runde Biotechnology and Yangzhou Rixing Bio-tech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glucosamine Hydrochloride API market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glucosamine Hydrochloride API Market by Company
Andhra Medi Pharma
Bioiberica
KOYO Chemical
Panvo Organics
TSI
Wanbury Limited
Fujian huakang pharmaceutical
Shandong Runde Biotechnology
Yangzhou Rixing Bio-tech
Zhejiang ChengYi Pharmaceutical
Zhejiang Hailisheng Pharmaceutical
Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
Glucosamine Hydrochloride API Segment by Type
Shell Extraction
Fermentation Production
Glucosamine Hydrochloride API Segment by Application
Pharmaceutical
Health Products
Glucosamine Hydrochloride API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucosamine Hydrochloride API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucosamine Hydrochloride API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucosamine Hydrochloride API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glucosamine Hydrochloride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glucosamine Hydrochloride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glucosamine Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Shell Extraction
- Fermentation Production
Applications
- Pharmaceutical
- Health Products
Companies covered
- Andhra Medi Pharma
- Bioiberica
- KOYO Chemical
- Panvo Organics
- TSI
- Wanbury Limited
- Fujian huakang pharmaceutical
- Shandong Runde Biotechnology
- Yangzhou Rixing Bio-tech
- Zhejiang ChengYi Pharmaceutical
- Zhejiang Hailisheng Pharmaceutical
- Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glucosamine Hydrochloride API Market Size (2021-2032)
- 2.2.2 Global Glucosamine Hydrochloride API Sales (2021-2032)
- 2.2.3 Global Glucosamine Hydrochloride API Market Average Price (2021-2032)
- 2.3 Glucosamine Hydrochloride API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Shell Extraction
- 2.3.3 Fermentation Production
- 2.4 Glucosamine Hydrochloride API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical
- 2.4.3 Health Products
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glucosamine Hydrochloride API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glucosamine Hydrochloride API Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Glucosamine Hydrochloride API Revenue of Manufacturers (2021-2026)
- 3.4 Global Glucosamine Hydrochloride API Average Price by Manufacturers (2021-2026)
- 3.5 Global Glucosamine Hydrochloride API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glucosamine Hydrochloride API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glucosamine Hydrochloride API, Product Type & Application
- 3.8 Global Manufacturers of Glucosamine Hydrochloride API, Established Date
- 3.9 Global Glucosamine Hydrochloride API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Andhra Medi Pharma
- 4.1.1 Andhra Medi Pharma Company Information
- 4.1.2 Andhra Medi Pharma Business Overview
- 4.1.3 Andhra Medi Pharma Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Andhra Medi Pharma Glucosamine Hydrochloride API Product Portfolio
- 4.1.5 Andhra Medi Pharma Recent Developments
- 4.2 Bioiberica
- 4.2.1 Bioiberica Company Information
- 4.2.2 Bioiberica Business Overview
- 4.2.3 Bioiberica Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bioiberica Glucosamine Hydrochloride API Product Portfolio
- 4.2.5 Bioiberica Recent Developments
- 4.3 KOYO Chemical
- 4.3.1 KOYO Chemical Company Information
- 4.3.2 KOYO Chemical Business Overview
- 4.3.3 KOYO Chemical Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 KOYO Chemical Glucosamine Hydrochloride API Product Portfolio
- 4.3.5 KOYO Chemical Recent Developments
- 4.4 Panvo Organics
- 4.4.1 Panvo Organics Company Information
- 4.4.2 Panvo Organics Business Overview
- 4.4.3 Panvo Organics Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Panvo Organics Glucosamine Hydrochloride API Product Portfolio
- 4.4.5 Panvo Organics Recent Developments
- 4.5 TSI
- 4.5.1 TSI Company Information
- 4.5.2 TSI Business Overview
- 4.5.3 TSI Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TSI Glucosamine Hydrochloride API Product Portfolio
- 4.5.5 TSI Recent Developments
- 4.6 Wanbury Limited
- 4.6.1 Wanbury Limited Company Information
- 4.6.2 Wanbury Limited Business Overview
- 4.6.3 Wanbury Limited Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Wanbury Limited Glucosamine Hydrochloride API Product Portfolio
- 4.6.5 Wanbury Limited Recent Developments
- 4.7 Fujian huakang pharmaceutical
- 4.7.1 Fujian huakang pharmaceutical Company Information
- 4.7.2 Fujian huakang pharmaceutical Business Overview
- 4.7.3 Fujian huakang pharmaceutical Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fujian huakang pharmaceutical Glucosamine Hydrochloride API Product Portfolio
- 4.7.5 Fujian huakang pharmaceutical Recent Developments
- 4.8 Shandong Runde Biotechnology
- 4.8.1 Shandong Runde Biotechnology Company Information
- 4.8.2 Shandong Runde Biotechnology Business Overview
- 4.8.3 Shandong Runde Biotechnology Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shandong Runde Biotechnology Glucosamine Hydrochloride API Product Portfolio
- 4.8.5 Shandong Runde Biotechnology Recent Developments
- 4.9 Yangzhou Rixing Bio-tech
- 4.9.1 Yangzhou Rixing Bio-tech Company Information
- 4.9.2 Yangzhou Rixing Bio-tech Business Overview
- 4.9.3 Yangzhou Rixing Bio-tech Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Yangzhou Rixing Bio-tech Glucosamine Hydrochloride API Product Portfolio
- 4.9.5 Yangzhou Rixing Bio-tech Recent Developments
- 4.10 Zhejiang ChengYi Pharmaceutical
- 4.10.1 Zhejiang ChengYi Pharmaceutical Company Information
- 4.10.2 Zhejiang ChengYi Pharmaceutical Business Overview
- 4.10.3 Zhejiang ChengYi Pharmaceutical Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Zhejiang ChengYi Pharmaceutical Glucosamine Hydrochloride API Product Portfolio
- 4.10.5 Zhejiang ChengYi Pharmaceutical Recent Developments
- 4.11 Zhejiang Hailisheng Pharmaceutical
- 4.11.1 Zhejiang Hailisheng Pharmaceutical Company Information
- 4.11.2 Zhejiang Hailisheng Pharmaceutical Business Overview
- 4.11.3 Zhejiang Hailisheng Pharmaceutical Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Zhejiang Hailisheng Pharmaceutical Glucosamine Hydrochloride API Product Portfolio
- 4.11.5 Zhejiang Hailisheng Pharmaceutical Recent Developments
- 4.12 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
- 4.12.1 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Company Information
- 4.12.2 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Business Overview
- 4.12.3 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Glucosamine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Glucosamine Hydrochloride API Product Portfolio
- 4.12.5 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Recent Developments
5 Global Glucosamine Hydrochloride API Market Scenario by Region
- 5.1 Global Glucosamine Hydrochloride API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glucosamine Hydrochloride API Sales by Region: 2021-2032
- 5.2.1 Global Glucosamine Hydrochloride API Sales by Region: 2021-2026
- 5.2.2 Global Glucosamine Hydrochloride API Sales by Region: 2027-2032
- 5.3 Global Glucosamine Hydrochloride API Revenue by Region: 2021-2032
- 5.3.1 Global Glucosamine Hydrochloride API Revenue by Region: 2021-2026
- 5.3.2 Global Glucosamine Hydrochloride API Revenue by Region: 2027-2032
- 5.4 North America Glucosamine Hydrochloride API Market Facts & Figures by Country
- 5.4.1 North America Glucosamine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glucosamine Hydrochloride API Sales by Country (2021-2032)
- 5.4.3 North America Glucosamine Hydrochloride API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glucosamine Hydrochloride API Market Facts & Figures by Country
- 5.5.1 Europe Glucosamine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glucosamine Hydrochloride API Sales by Country (2021-2032)
- 5.5.3 Europe Glucosamine Hydrochloride API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glucosamine Hydrochloride API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glucosamine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glucosamine Hydrochloride API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glucosamine Hydrochloride API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glucosamine Hydrochloride API Market Facts & Figures by Country
- 5.7.1 South America Glucosamine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glucosamine Hydrochloride API Sales by Country (2021-2032)
- 5.7.3 South America Glucosamine Hydrochloride API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glucosamine Hydrochloride API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glucosamine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glucosamine Hydrochloride API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glucosamine Hydrochloride API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glucosamine Hydrochloride API Sales by Type (2021-2032)
- 6.1.1 Global Glucosamine Hydrochloride API Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Glucosamine Hydrochloride API Sales Market Share by Type (2021-2032)
- 6.2 Global Glucosamine Hydrochloride API Revenue by Type (2021-2032)
- 6.2.1 Global Glucosamine Hydrochloride API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glucosamine Hydrochloride API Revenue Market Share by Type (2021-2032)
- 6.3 Global Glucosamine Hydrochloride API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glucosamine Hydrochloride API Sales by Application (2021-2032)
- 7.1.1 Global Glucosamine Hydrochloride API Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Glucosamine Hydrochloride API Sales Market Share by Application (2021-2032)
- 7.2 Global Glucosamine Hydrochloride API Revenue by Application (2021-2032)
- 7.2.1 Global Glucosamine Hydrochloride API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glucosamine Hydrochloride API Revenue Market Share by Application (2021-2032)
- 7.3 Global Glucosamine Hydrochloride API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glucosamine Hydrochloride API Value Chain Analysis
- 8.1.1 Glucosamine Hydrochloride API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glucosamine Hydrochloride API Production Mode & Process
- 8.2 Glucosamine Hydrochloride API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glucosamine Hydrochloride API Distributors
- 8.2.3 Glucosamine Hydrochloride API Customers
9 Global Glucosamine Hydrochloride API Analyzing Market Dynamics
- 9.1 Glucosamine Hydrochloride API Industry Trends
- 9.2 Glucosamine Hydrochloride API Industry Drivers
- 9.3 Glucosamine Hydrochloride API Industry Opportunities and Challenges
- 9.4 Glucosamine Hydrochloride API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst